Biomaterials and Tissue Engineering

Institutes, centers and labs related to Biomaterials and Tissue Engineering

Plant Leaves

Steinmetz Lab

Develops plant virus-based drug delivery, immunotherapies, clinical imaging and material synthesis.

Red Blood Cells

Sen Gupta Lab

Bio-inspired Engineering for Advanced Therapies

Studies multi-scale mechanisms of vascular and cancer pathologies, and develops bio-inspired materials and drug delivery systems to treat these disease conditions.


Capadona Lab

Studies the conditions that lead to neural implant failure and explores avenues to improve performance of these devices.

Faculty who conduct research in Biomaterials and Tissue Engineering

Profile Photo

Jeff Capadona

Associate Professor, Biomedical Engineering

Engineers biomaterials-based strategies to improve the performance and longevity of central nervous system implanted devices

Profile Photo

Steven Eppell

Associate Professor, Biomedical Engineering

Designs, synthesizes and tests orthopedic biomaterials using biomimetic strategies emphasizing nanoscale structures and self-assembly

Profile Photo

Clare Rimnac

Wilbert J. Austin Professor of Engineering
Professor, Mechanical and Aerospace Engineering

Advances the long-term performance of implants and structural bone allografts through material analysis and characterization

Profile Photo

Sam Senyo

Assistant Professor, Biomedical Engineering

Applies tissue engineering to study human biology and improve human health

Profile Photo

Mei Zhang

Assistant Professor, Biomedical Engineering

Significant advances have been made in the field of cancer immunotherapy by orchestrating the body’s immune system to eradicate cancer cells. However, safety and efficacy concerns stemming from the systemic delivery of immunomodulatory compounds limits cancer immunotherapies expansion and application. In this context, immune modulatory biomaterials and nanoparticles presents a number of advantages, such as targeted modulation of immune cells, enhanced clinical outcomes, and reduced adverse events, which may result in enhanced cancer immunotherapies. Therefore, key goal of my research is to engineer enhanced immunity through the design of non-viral non-toxic biomaterial and nanomaterials that control the immune responses against cancer.